Baseline heterogeneity in glucose metabolism marks the risk for type 1 diabetes and complicates secondary prevention. Link to publication Citation for published version (APA): Larsson, H., Larsson, C., & Lernmark, Å. (2015). Baseline heterogeneity in glucose metabolism marks the risk for type 1 diabetes and complicates secondary prevention. Acta Diabetologica, 52(3), 473-481. DOI: 10.1007/s00592-014-0680-1General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.• You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal
AbstractNon-diabetic children with multiple islet autoantibodies were recruited to a secondary prevention trial.The objective was to determine the predictive value of baseline 1) HbA1c and metabolic variables derived from intravenous (IvGTT) and oral (OGTT) glucose tolerance tests, 2) insulin resistance and 3)number, type and levels of islet autoantibodies, for progression to type 1 diabetes. Children (n=50, median 5.1 (4-17.9) years) with autoantibodies to glutamate-decarboxylase (GAD65A) and at least one